34
Growth Score in past quarter
pts
Heat Score 34 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
515607
Labcorp Drug Development is a life sciences company that brings diagnostic testing and drug development together.
Mark Sausen: Head of Technology Innovation, PGDxPast Role: Personal Genome Diagnostics, Vice President, Technology Innovation- Crystal Icenhour: Microbiome & Specialty Infectious Disease DirectorPast Role: Aperiomics, CEO
About the Company
Labcorp Drug Development provides clinical trial services. Their services include drug development services, toxicology services, central laboratory services, clinical trial management, research, life sciences, clinical research, preclinical solutions, oncology, market access, rare diseases, orphan drugs, biotech, pharma, pharmaceuticals, crop
protection, clinical trial optimization, clinical trials, cell, gene therapy, nash, pharmacovigilance, patient support, patient safety, infectious diseases, immuno-oncology, commercialization, pediatrics, kidney disease, inflammation, bioassays, bioanalysis, large molecules, small molecules, clinical trial informatics, preclinical services, and nonclinical services.